BioSpace News Archive

Business

LianBio Provides Corporate Update and Reports Third Quarter 2021 Financial Results

LianBio, a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, provided a corporate update and reported financial results for the third quarter ended September 30, 2021.

December 9, 2021
·
11 min read
Pharm Country

Context Therapeutics® Announces Positive Data from ONA-XR in Early Breast Cancer at 2021 San Antonio Breast Cancer Symposium

Context Therapeutics Inc. (Nasdaq: CNTX), today announced that data from the window-of-opportunity clinical trial of onapristone extended release (ONA-XR) in postmenopausal patients with progesterone receptor positive (PR+) early breast cancer demonstrated ONA-XR significantly increased suppression of tumor cell proliferation.

December 9, 2021
·
6 min read
Biotech Beach

Analysis Presented at SABCS 2021 Confirms MammaPrint® and BluePrint® Predict Outcomes Following Neoadjuvant Chemotherapy

Agendia, Inc., a world leader in precision oncology for breast cancer, today shared data demonstrating the ability of MammaPrint® and BluePrint® to predict patient outcomes following neoadjuvant chemotherapy (NAC) at the 2021 San Antonio Breast Cancer Symposium (SABCS 2021).

December 9, 2021
·
4 min read
Drug Development

Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere’s Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema

Simcere Pharmaceutical Group and Aeromics, Inc. today announced that Simcere dosed the first subjects in the SIM0307 (AER-271) Phase I study conducted in Beijing Tiantan Hospital.

December 9, 2021
·
4 min read